Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Vordermark

Showing results (41-50 of 222) with videos related to

Pageof 23
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cellsDirk Vordermark, Anja Kaffer, Susanne Riedl, et al.
Radiation Oncology (London, England)|January 15, 2008
Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?Matthias Guckenberger, Kurt Baier, Anne Richter, et al.
Plos One|February 27, 2020
Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developmentsChristoph Evers, Christian Ostheimer, Frank Sieker, et al.
Oncology Reports|October 5, 2007
Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapyDirk Vordermark, Andrea Lackenbauer, Jörn Wulf, et al.
Scientific Reports|July 11, 2024
Population based study on the progress in survival of primarily metastatic lung cancer patients in GermanyTherese Tzschoppe, Julia Ohlinger, Dirk Vordermark, et al.
BMC Cancer|November 23, 2014
Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancerChristian Ostheimer, Matthias Bache, Antje Güttler, et al.
Journal of Cancer Research and Clinical Oncology|August 30, 2023
Treatment patterns in stage III non‑small‑cell lung cancer patients: a population‑based study using German cancer registry dataAhmed Bedir, Sneha Mehrotra, Jessica Gnüchtel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 11, 2005
Radiotherapy of prostate cancer with multileaf collimators (MLCs) optimization of the undulating dose distribution at the MLC edgeOliver Koelbl, Franz Schwab, Klaus Bratengeier, et al.
Frontiers in Immunology|November 3, 2017
Dynamics of Heat Shock Protein 70 Serum Levels As a Predictor of Clinical Response in Non-Small-Cell Lung Cancer and Correlation with the Hypoxia-Related Marker OsteopontinChristian Ostheimer, Sophie Gunther, Matthias Bache, et al.
Radiation Oncology Journal|December 14, 2016
Dosimetric comparison of intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) in total scalp irradiation: a single institutional experienceChristian Ostheimer, Patrick Hübsch, Martin Janich, et al.
Pageof 23

Showing results (41-50 of 222) with videos related to

Sort By:
Pageof 23
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cellsDirk Vordermark, Anja Kaffer, Susanne Riedl, et al.
Radiation Oncology (London, England)|January 15, 2008
Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?Matthias Guckenberger, Kurt Baier, Anne Richter, et al.
Plos One|February 27, 2020
Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developmentsChristoph Evers, Christian Ostheimer, Frank Sieker, et al.
Oncology Reports|October 5, 2007
Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapyDirk Vordermark, Andrea Lackenbauer, Jörn Wulf, et al.
Scientific Reports|July 11, 2024
Population based study on the progress in survival of primarily metastatic lung cancer patients in GermanyTherese Tzschoppe, Julia Ohlinger, Dirk Vordermark, et al.
BMC Cancer|November 23, 2014
Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancerChristian Ostheimer, Matthias Bache, Antje Güttler, et al.
Journal of Cancer Research and Clinical Oncology|August 30, 2023
Treatment patterns in stage III non‑small‑cell lung cancer patients: a population‑based study using German cancer registry dataAhmed Bedir, Sneha Mehrotra, Jessica Gnüchtel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 11, 2005
Radiotherapy of prostate cancer with multileaf collimators (MLCs) optimization of the undulating dose distribution at the MLC edgeOliver Koelbl, Franz Schwab, Klaus Bratengeier, et al.
Frontiers in Immunology|November 3, 2017
Dynamics of Heat Shock Protein 70 Serum Levels As a Predictor of Clinical Response in Non-Small-Cell Lung Cancer and Correlation with the Hypoxia-Related Marker OsteopontinChristian Ostheimer, Sophie Gunther, Matthias Bache, et al.
Radiation Oncology Journal|December 14, 2016
Dosimetric comparison of intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) in total scalp irradiation: a single institutional experienceChristian Ostheimer, Patrick Hübsch, Martin Janich, et al.
Pageof 23